Results 21 to 30 of about 967 (120)

Placental biomarker and fetoplacental Doppler abnormalities are strongly associated with placental pathology in pregnancies with small‐for‐gestational‐age fetus: prospective study

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 6, Page 749-760, June 2025.
ABSTRACT Objective Placental dysfunction can result in small‐for‐gestational age (SGA) or fetal growth restriction (FGR). The aim of this prospective cohort study was to assess the association of the cerebroplacental ratio (CPR) and other more conventional fetoplacental Doppler indices, circulating placental growth factor (PlGF) levels and soluble fms ...
J. Hong, K. Crawford, E. Cavanagh, V. Clifton, F. da Silva Costa, A. V. Perkins, S. Kumar   +6 more
wiley   +1 more source

Screening for pre‐eclampsia using pregnancy‐associated plasma protein‐A or placental growth factor measurements in blood samples collected at 8–14 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 5, Page 567-574, May 2025.
ABSTRACT Objectives To assess the value of pregnancy‐associated plasma protein‐A (PAPP‐A) in screening for preterm pre‐eclampsia (PE) (delivery < 37 weeks' gestation) measured in maternal blood samples collected before 11 weeks, and to compare the screening performance of PAPP‐A with that of placental growth factor (PlGF) from blood samples collected ...
L. Rode, A. Wright, D. Wright, M. Overgaard, L. Sperling, P. Sandager, P. Nørgaard, F. S. Jørgensen, H. Zingenberg, I. Riishede, A. Tabor, C. K. Ekelund, the PRESIDE Study Group, M. R. Andersen, L. Bathum, C. A. Juel Jensen, C. S. Knudsen, N. G. Pedersen, K. Pihl, C. Vedel, H. Skov, S. R. Wagner   +21 more
wiley   +1 more source

N‐terminal pro B‐type natriuretic peptide as biomarker to predict pre‐eclampsia and maternal–fetal complications

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 4, Page 447-455, April 2025.
ABSTRACT Objective A soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio cut‐off of 38 is currently considered optimal for ruling out pre‐eclampsia (PE); however, implementation of this ratio in clinical practice is limited.
M. N. Nan, C. Garrido‐Giménez, Á. Garcia‐Osuna, P. Garcia Manau, J. Ullmo, J. Mora, O. Sanchez‐Garcia, J. Platero, M. Cruz‐Lemini, E. Llurba, on behalf of the EuroPE working group, M. Vila‐Cortés, M. J. Pelegay, M. Ricart, B. Muñoz‐Abellana, X. Gabaldó Barrios   +15 more
wiley   +1 more source

Association of maternal body mass index with hemodynamic and vascular alterations at 35–37 weeks' gestation

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 3, Page 303-310, March 2025.
ABSTRACT Objective Globally, one in four pregnant women is classified as overweight or obese, based on their prepregnancy body mass index (BMI). Obese pregnant women are at increased risk of adverse pregnancy outcomes and long‐term cardiovascular disease that occurs earlier in life.
M. Charakida, C. Chatzakis, L. A. Magee, A. Syngelaki, T. Mansukhani, P. von Dadelszen, K. H. Nicolaides   +6 more
wiley   +1 more source

Prediction of pre‐eclampsia using maternal hemodynamic parameters at 12 + 0 to 15 + 6 weeks

Ultrasound in Obstetrics &Gynecology, Volume 65, Issue 2, Page 173-182, February 2025.
ABSTRACT Objectives To compare the maternal hemodynamic profile at 12 + 0 to 15 + 6 weeks' gestation in women who subsequently developed pre‐eclampsia (PE) and those who did not, and to assess the screening performance of maternal hemodynamic parameters for PE in combination with the Fetal Medicine Foundation (FMF) triple test, including maternal ...
X. Wang, D. S. Sahota, L. Wong, L. Nguyen‐Hoang, Y. Chen, A. S. T. Tai, F. Liu, S. Ling Lau, A. P. W. Lee, L. C. Poon   +9 more
wiley   +1 more source

Intermanufacturer assessment of diagnostic performance of angiogenic ratio vs glycosylated fibronectin in women with suspected pre‐eclampsia

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 5, Page 620-625, November 2024.
ABSTRACT Objective To compare the diagnostic performance of different manufacturers' immunoassays for the soluble fms‐like tyrosine kinase‐1 (sFlt‐1)‐to‐placental growth factor (PlGF) ratio with that of a point‐of‐care (PoC) test for glycosylated fibronectin (GlyFn) in women with suspected pre‐eclampsia (PE).
I. Y. M. Wah, D. S. Sahota, N. K. L. Wong, N. M. W. Lee, C. J. Liu, C. S. L. Lau, H. H. Y. Leung, L. C. Poon   +7 more
wiley   +1 more source

子痫前期对围生儿的影响

Zhongguo shiyan zhenduanxue, 2007
目的探讨子痫前期对围生儿的影响。方法对2003年7月至2005年12月在我院分娩的229例子痫前期围生儿情况与随机抽取同期住院分娩的230例正常孕妇的围生儿情况进行回顾性分析。结果子痫前期早产儿、小于胎龄儿、新生儿窒息发生率及围生儿死亡率高于正常孕妇 ...
孙波, 赵艳晖, 张炜阳, 吴富菊
doaj  

Maternal ethnicity and socioeconomic deprivation: influence on adverse pregnancy outcomes

Ultrasound in Obstetrics &Gynecology, Volume 64, Issue 2, Page 187-192, August 2024.
ABSTRACT Objective To evaluate the relative importance of ethnicity and socioeconomic deprivation in determining the likelihood and prevalence of placentally derived composite of adverse pregnancy outcomes (CAPO) and composite of severe adverse pregnancy outcomes (CAPO‐S).
M. Minopoli, L. Noël, A. Dagge, G. Blayney, A. Bhide, B. Thilaganathan   +5 more
wiley   +1 more source

孕妇血清妊娠相关蛋白-A及超敏C反应蛋白在子痫前期临床检测意义分析

Zhongguo shiyan zhenduanxue, 2014
目的探讨孕妇血清妊娠相关蛋白-A及超敏C反应蛋白在子痫前期的临床检测意义。方法选择我院2010年7月至2013年7月期间收治的子痫前期患者共221例,上述患者根据子痫前期严重程度分为轻度子痫前期共144例,重度子痫前期患者共77例,分别作为轻度组和重度组。同时选择在我院定期产前检测的正常孕妇50例,作为对照组。采用酶联免疫吸附实验测定血清妊娠相关蛋白A水平;采用免疫发光法测定超敏C反应蛋白水平。结果重度组和轻度组的血清超敏C反应蛋白、妊娠相关蛋白A水平分别高于对照组,差异有统计学意义 ...
邓仙桃
doaj  

Performance of machine‐learning approach for prediction of pre‐eclampsia in a middle‐income country

Ultrasound in Obstetrics &Gynecology, Volume 63, Issue 3, Page 350-357, March 2024.
ABSTRACT Objective Pre‐eclampsia (PE) is a serious complication of pregnancy associated with maternal and fetal morbidity and mortality. As current prediction models have limitations and may not be applicable in resource‐limited settings, we aimed to develop a machine‐learning (ML) algorithm that offers a potential solution for developing accurate and ...
J. Torres‐Torres, J. R. Villafan‐Bernal, R. J. Martinez‐Portilla, J. A. Hidalgo‐Carrera, G. Estrada‐Gutierrez, R. Adalid‐Martinez‐Cisneros, L. Rojas‐Zepeda, S. Acevedo‐Gallegos, D. M. Camarena‐Cabrera, M. Y. Cruz‐Martínez, S. Espino‐y‐Sosa   +10 more
wiley   +1 more source